Weight Loss Intervention for Breast Cancer Recurrence Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if weight loss can help prevent breast cancer recurrence in overweight or obese women. Participants will either join a weight loss program or receive health education focused on healthy living. Women recently diagnosed with breast cancer, who have a BMI of 27 or higher and can walk at least two blocks, may be suitable for this study. By comparing these groups, researchers hope to assess whether weight loss should be included in breast cancer treatment plans. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking treatment strategies.
Do I need to stop my current medications to join the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, it does mention that hormonal therapy and certain other treatments are acceptable during the trial. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that weight loss programs for breast cancer survivors are generally safe and well-tolerated. One study examined a 24-week program using a mobile app for coaching and found it effective for these survivors. Participants reported better weight control and healthier lifestyle choices without major side effects. Another study involving wellness coaching also demonstrated benefits in weight loss and increased physical activity, again without serious problems. Additionally, the Breast Cancer Weight Loss (BWEL) study found that a phone-based coaching program helped women lose weight safely. These findings suggest that structured weight loss programs, like the one in this trial, are likely safe for participants.12345
Why are researchers excited about this trial?
Researchers are excited about the Weight Loss Intervention for Breast Cancer Recurrence Prevention because it combines lifestyle changes with a personalized approach to health education. Unlike typical treatments that focus solely on medication or surgery, this intervention emphasizes a structured weight loss plan tailored to each participant, involving caloric restriction and physical activity goals. The program is delivered through convenient semi-structured phone calls by trained coaches, making it accessible and adaptable to individual needs. This holistic approach could offer a promising new way to prevent breast cancer recurrence by addressing overall health and lifestyle, which is not typically targeted by standard care options.
What evidence suggests that this trial's treatments could be effective for preventing breast cancer recurrence?
This trial will compare two approaches: a Health Education Program and a combined Health Education Program with a Weight Loss Intervention. Studies have shown that losing weight can lower the risk of breast cancer returning. Research has indicated that a 6-month lifestyle program improved the eating habits of overweight or obese breast cancer survivors. One study found that a mobile app-based coaching program helped these survivors lose weight over 24 weeks. Additionally, other research showed that participants in a remote weight loss program lost an average of 4.7% of their starting weight after one year. These findings suggest that weight loss efforts might reduce the chances of breast cancer recurrence for those who are overweight or obese.26789
Who Is on the Research Team?
Jennifer Ligibel, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
Women over 18 with invasive breast cancer diagnosed within the last 14 months, who have completed initial treatments and are overweight (BMI ≥27 kg/m2). Participants must be able to walk two blocks and read English. They should not have had other cancers in the past 4 years, severe diseases that limit life expectancy or activity, or serious digestive issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 2-year telephone-based weight loss intervention focusing on caloric restriction and physical activity, supplemented with print and online materials
Follow-up
Participants are monitored for safety and effectiveness after treatment, with follow-up every 6 months for the first 3 years and then annually until 10 years from registration
What Are the Treatments Tested in This Trial?
Interventions
- Health Education Program
- Weight Loss Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alliance for Clinical Trials in Oncology
Lead Sponsor
NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)
Collaborator
Canadian Cancer Trials Group
Collaborator
National Cancer Institute (NCI)
Collaborator
Division of Cancer Control
Collaborator